Acta Gastroenterol Latinoam

1. KHOLWADWALA AS, Quigley EMM
   Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth: Are They Overdiagnosed?
   Acta Gastroenterol Latinoam. 2025;55:276-291.
   

   >> Share

   
   

   
   Adv Mind Body Med

2. ARCHANA B, Priyathersini N, Mathangi DC
   Improvement from Irritable Bowel Syndrome and Anxiety Through Integrative Yoga, Meditation and Naturopathy: A Case Report.
   Adv Mind Body Med. 2026 Mar 11:ADV1463.
   

   >> Share

   
   

   
   Arch Dermatol Res

3. VAIDYULA VR, Kundu RV
   Vitiligo and Risk of Gastrointestinal Disorders in the United States: A Case-Control Study.
   Arch Dermatol Res. 2026;318:119.
   

   >> Share

   
   

   
   Cureus

4. FALL AAA, Gueye MN, Diouf MN, Toure B, et al
   Functional Bowel Disorders: A Retrospective Descriptive Study in Dakar, Senegal.
   Cureus. 2026;18:e103082.
   

   >> Share

   
   

   
   Drug Metab Dispos

5. ALSMADI MM
   P-glycoprotein-mediated impairment of doxorubicin clearance in inflammatory bowel disorders: Mechanistic insights from rat studies and whole-body physiologically based pharmacokinetic modeling.
   Drug Metab Dispos. 2026;54:100254.
   

   >> Share

   
   

   
   EBioMedicine

6. BURNS GL, Roberts F, Wark JA, Fowler S, et al
   Serological and faecal markers of irritable bowel syndrome: a systematic review and meta-analysis.
   EBioMedicine. 2026;126:106198.
   

   >> Share

   
   

   
   Food Res Int

7. BAHETI R, Deshkar S, Jadhav S, Mule K, et al
   Interplay of probiotics, prebiotics, synbiotics and postbiotics: a review of their therapeutic potential for gastrointestinal inflammation.
   Food Res Int. 2026;230:118598.
   

   >> Share

   
   

   
   Front Cardiovasc Med

8. STENMAN E, Bolmsjo BB, Nilholm C, Grundberg A, et al
   Poor self-rated health in individuals with irritable bowel syndrome but no increased 10-year cardiovascular risk: results from a Swedish population-based screening program.
   Front Cardiovasc Med. 2026;13:1702012.
   

   >> Share

   
   

   
   Front Immunol

9. HUO T, Huang X, Liao J, Zhang H, et al
   The bidirectional effects and mechanisms of the oral and gut microbiomes: a narrative review.
   Front Immunol. 2026;17:1697413.
   

   >> Share

   
   

   
   Int Immunopharmacol

10. CHEN L, Yan Y, Shi X, Chen R, et al
    Central amygdala HDAC6 contributes to visceral hypersensitivity and affective comorbidities in IBS-like rats.
    Int Immunopharmacol. 2026;176:116466.
    

    >> Share

    
    

    
    Int J Med Sci

11. TANG W, Wang J, Wang W, Xue J, et al
    Reviewing the Peripheral and Central Mechanisms of Visceral Hypersensitivity in Intestinal Disorders.
    Int J Med Sci. 2026;23:1121-1143.
    

    >> Share

    
    

    
    Int J Rheum Dis

12. HUANG LH, Wang YH, Wu TJ, Lin FY, et al
    Association Between Rheumatoid Arthritis and Gastrointestinal Comorbidities: Evidence From Taiwan's National Health Insurance Database.
    Int J Rheum Dis. 2026;29:e70588.
    

    >> Share

    
    

    
    J Gastroenterol Hepatol

13. TANG ASP, Quek J, Sulaimi F, Sim B, et al
    Probiotics for Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis With Trial Sequential Analysis.
    J Gastroenterol Hepatol. 2026 Mar 12. doi: 10.1111/jgh.70322.
    

    >> Share

    
    

    
    J Neurogastroenterol Motil

14. KIM YS, Park SY, Kang SJ, Lee MW, et al
    Clinical Guidance and Practical Recommendations for Probiotic Use in Patients With Irritable Bowel Syndrome, Functional Constipation, and Clostridium difficile Infection Considering Sex-based Differences.
    J Neurogastroenterol Motil. 2026 Mar 10. doi: 10.5056/jnm25221.
    

    >> Share

    
    

    
    J Psychosom Res

15. TATTAN M, Hanssen DJC, Rosmalen JGM
    Who receives a diagnostic label for fibromyalgia, chronic fatigue syndrome, and irritable bowel syndrome? A study in the lifelines cohort.
    J Psychosom Res. 2026;205:112609.
    

    >> Share

    
    

    
    Neurogastroenterol Motil

16. NEWMAN-BOOTH A, Fairhurst E, Vasant DH
    Racial Disparities in the Diagnosis and Management Between Secondary Care Ethnic Minority and White British Patients With Irritable Bowel Syndrome.
    Neurogastroenterol Motil. 2026;38:e70272.
    

    >> Share

    
    
17. VERAZA DI, Waseem MR, Venezia J, Montero AM, et al
    Perceived Utility of Cognitive Behavioral Therapy in People With Bowel Disorders of Gut-Brain Interaction.
    Neurogastroenterol Motil. 2026;38:e70283.
    

    >> Share

    
    
18. SUJAN AC, Major J, Groenewald CB, Rabbitts JA, et al
    National Medical Expenditures Associated With Pediatric Disorders of Gut-Brain Interaction in the United States.
    Neurogastroenterol Motil. 2026;38:e70279.
    

    >> Share

    
    

    
    Ter Arkh

19. BYKOVA SV, Dbar SR, Sabelnikova EA, Belostotsky NI, et al
    [Justification for the use of a FODMAP diet in patients with irritable bowel syndrome: focus on small intestinal disaccharidase activity].
    Ter Arkh. 2026;98:99-104.
    

    >> Share

    
    

    
    World J Methodol

20. PRODAN R, Soldera J
    Mirtazapine for the treatment of irritable bowel syndrome: A systematic review.
    World J Methodol. 2026;16:107908.
    

    >> Share

    
    
21. SHAH Q, Soldera J
    Exploring effectiveness of Metronidazole, Bismuth, and Rifaximin in treating small intestinal bacterial overgrowth and irritable bowel syndrome: A systematic review.
    World J Methodol. 2026;16:107169.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share